1 / 27

Introduction to Clinical Pharmacology Chapter 34- Antihyperlipidemic Drugs

Introduction to Clinical Pharmacology Chapter 34- Antihyperlipidemic Drugs. Lipoproteins. Low-density lipoproteins (LDL): Transport cholesterol to the peripheral cells Lipoprotein profile-total cholesterol, LDL, HDL, triglycerides Elevation of LDL: Atherosclerotic plaque formation

beth
Download Presentation

Introduction to Clinical Pharmacology Chapter 34- Antihyperlipidemic Drugs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Introduction to Clinical PharmacologyChapter 34-Antihyperlipidemic Drugs

  2. Lipoproteins • Low-density lipoproteins (LDL): • Transport cholesterol to the peripheral cells • Lipoprotein profile-total cholesterol, LDL, HDL, triglycerides • Elevation of LDL: • Atherosclerotic plaque formation • Increases the risk for heart disease • High-density lipoproteins (HDL): • Take cholesterol from the peripheral cells and transport it to the liver

  3. Cholesterol Levels • HDL cholesterol: Protects against heart diseases • Higher the LDL level: Greater the risk for heart disease • Drugs used to treat hyperlipidemia: • Bile acid sequestrants • HMG-CoA reductase inhibitors • Fibric acid derivatives • Niacin

  4. HMG-CoA Reductase Inhibitors: Actions • Statins** • HMG-CoA reductase: • An enzyme that is a catalyst during the manufacture of cholesterol • Inhibits the manufacture of cholesterol or promotes the breakdown of cholesterol • Lowers the blood levels of cholesterol and serum triglycerides • Increases blood levels of HDLs

  5. HMG-CoA Reductase Inhibitors: Uses • As adjunct to diet in the treatment of hyperlipidemia • For primary prevention of coronary events • MI • For secondary prevention of cardiovascular events • TIA/stroke

  6. HMG-CoAReductase Inhibitors: Adverse Reactions • Central nervous system reactions: • Headache, blurred vision, dizziness, insomnia • Gastrointestinal reactions: • Flatulence, abdominal pain, cramping, constipation, nausea • Other: • Elevated CPK level, Rhabdomyolysis with possible renal failure • Pharyngitis with use of rosuvastatin/Crestor

  7. HMG-CoA Reductase Inhibitors: Contraindications And Precautions • Contraindicated in patients: • With hypersensitivity to the drugs, serious liver disorders • During pregnancy and lactation • Used cautiously in patients with: • History of alcoholism, acute infection, hypotension, trauma, endocrine disorders, visual disturbances, and myopathy

  8. Nursing alert • Pts taking cyclosporine, Asians and those with severe renal insufficiency are at risk for myopathy/rhabdomyolysis when taking rosuvastatin/Crestor

  9. HMG-CoA Reductase Inhibitors: Interactions

  10. Bile Acid Sequestrants: Actions and Use • Bile: Manufactured, secreted by liver • Stored in the gallbladder, emulsifies fat, lipids • Increased loss of bile acids: • Liver uses cholesterol to manufacture more bile • Used to treat: Hyperlipidemia; Pruritus associated with partial biliary obstruction

  11. Bile Acid Sequestrants: Adverse Reactions • Constipation • Aggravation of hemorrhoids • Abdominal cramps • Flatulence • Nausea • Increased bleeding tendencies related to vitamin K malabsorption, and vitamin A and D deficiencies

  12. Bile Acid Sequestrants: Contraindications And Precautions • Contraindicated in patients : • With known hypersensitivity to the drugs • With complete biliary obstruction • With liver disease • Used cautiously in patients: • With liver disease, kidney disease • During pregnancy and lactation

  13. Bile Acid Sequestrants : Interactions

  14. Bile Acid Sequestrants : Interactions (cont’d)

  15. Fibric Acid Derivatives:Actions • Clofibrate: • Stimulates liver to increase breakdown of very–low-density lipoproteins (VLDLs) to low-density lipoproteins (LDLs); Decreases liver synthesis of VLDLs and inhibites cholesterol formation • Fenofibrate: • Reduces VLDL; Stimulates catabolism of triglyceride-rich lipoproteins; Decreases plasma triglyceride, cholesterol

  16. Fibric Acid Derivatives:Actions (cont’d) • Gemfibrozil: • Increases excretion of cholesterol in the feces • Reduces the production of triglycerides by the liver • Lowers serum lipid levels

  17. Fibric Acid Derivatives: Uses • Clofibrate and gemfibrozil: • Used to treat individuals with very high serum triglyceride levels who are at risk for abdominal pain, pancreatitis • Fenofibrate: • Used as adjunctive treatment for reducing LDL, total cholesterol, triglycerides in patients with hyperlipidemia

  18. Fibric Acid Derivatives • Adverse Reactions: • Nausea, vomiting, GI upset, diarrhea, cholelithiasis or cholecystitis • Contraindicated in patients: • With hypersensitivity to the drugs and those with significant hepatic or renal dysfunction or primary biliary cirrhosis • Used cautiously in patients with: • Peptic ulcer disease, diabetes, during pregnancy and lactation

  19. Miscellaneous Antihyperlipidemic Drugs: Niacin • Action: Lowers blood lipid levels • Uses: Adjunctive therapy for lowering very high serum triglyceride levels in patients who are at risk for pancreatitis • Adverse reactions: • Gastrointestinal reactions: Nausea, vomiting, abdominal pain, diarrhea • Other reactions: Severe generalized flushing of the skin, sensation of warmth, severe itching or tingling-Niacin

  20. Miscellaneous Antihyperlipidemic Drugs: Contraindications And Precautions • Contraindicated in patients: • With known hypersensitivity to niacin, active peptic ulcer, hepatic dysfunction, and arterial bleeding • Used cautiously in patients with: • Renal dysfunction, high alcohol consumption, unstable angina, gout, pregnancy

  21. Nursing Process: Assessment • Preadministration assessment: • Take a dietary history; Record vital signs and weight; Inspect skin and eyelids for evidence of xanthomas • Ongoing assessment: • Monitor liver function tests, such as serum transaminase levels • Frequently monitor blood cholesterol and triglyceride levels • Periodic lipid profiles

  22. Nursing Process: Planning • Expected outcome: • Optimal response to therapy • Management of common adverse drug reactions • Understanding of the dietary measures necessary to reduce lipid and lipoprotein levels

  23. Nursing Process: Implementation • Promoting an optimal response to therapy: • Explain drug regimen and possible adverse reactions • Emphasize the importance of following printed dietary guidelines

  24. Nursing Process: Implementation • Monitoring and managing patient needs: • Constipation: Increase fluid intake, eat foods high in dietary fiber, exercise daily • Risk for imbalanced nutrition: Less Than Body Requirements • Bile acid sequestrants used for long-term therapy: Administer vitamins A, D in water-soluble form or parenterally

  25. Nursing Process: Implementation • Monitoring and managing patient needs (cont’d): • Potential complication: • Vitamin k deficiency: Include foods high in vitamin k in the patient’s diet • Rhabdomyolysis: Be alert for unexplained muscle pain, muscle tenderness, or weakness, especially if accompanied by malaise or fever

  26. Nursing Process: Implementation • Educating the patient and family: • Statins • Lovastatin is taken once daily, usually with the evening meal • Bile Acid resins • Colestipol granules-use 90 ml of liquid to mix • Fibric acid derivatives • Gemfibrozil-explain that dizziness or blurred vision may occur. Observe caution when driving or performing hazardous tasks

  27. Nursing Process: Evaluation • Therapeutic effect is achieved; Serum lipid levels are decreased • Adverse reactions are identified, reported, and managed successfully • Improved bowel movements • Nutritional vitamin needs will be met

More Related